Search results
Results from the WOW.Com Content Network
Dry eye affects both sexes, but it is slightly more common in females. It’s also found in folks who don’t get enough Vitamin A or omega-3 fatty acids. I was given a prescription at the time of ...
The Food and Drug Administration recently cautioned consumers against using 27 different kinds of eyedrops — its third eyedrop-related warning this year — leading Americans to question whether ...
Side effects in less than 10% of people include other eye problems such as itching, foreign body sensation or dry eye, as headache or hyperpigmentation (darkening) of the skin around the eye. [4] Hyperpigmentation is an adverse effect of bimatoprost, [5] while the others are fairly common for eye drops in general.
Latanoprost, sold under the brand name Xalatan among others, is a medication used to treat increased pressure inside the eye (intraocular pressure). [5] This includes ocular hypertension and open-angle glaucoma. [5] Latanaprost is applied as eye drops to the eyes. [5] Onset of effects is usually within four hours, and they last for up to a day.
The FDA recently cautioned against using dozens of kinds of eyedrops — its third warning this year — leading to some wondering whether any drops are safe to use. Eye doctors weigh in.
Bimatoprost, sold under the brand name Lumigan among others, is a medication used to treat high pressure inside the eye including glaucoma. [5] Specifically it is used for open angle glaucoma when other agents are not sufficient. [5] [6] It may also be used to increase the size of the eyelashes. [3] [4] It is used as an eye drop and effects ...
Frequency. ~20% [5] Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes. [2] Symptoms include dryness in the eye, irritation, redness, discharge, blurred vision, and easily fatigued eyes. Symptoms range from mild and occasional to severe and continuous. [3]
In general, eye drops have been recalled over the past year due to either contamination or a lack of sterility. Both are major issues, Aaron Zimmerman, O.D., a clinical professor at The Ohio State ...